Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel

Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis

Publication ,  Conference
Bylsma, L; Nielson, CM; Fryzek, J; Saad, H; Crawford, J
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2021

Duke Scholars

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

EISSN

1099-1557

ISSN

1053-8569

Publication Date

2021

Volume

30

Start / End Page

111 / 111

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bylsma, L., Nielson, C. M., Fryzek, J., Saad, H., & Crawford, J. (2021). Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 30, pp. 111–111).
Bylsma, Lauren, Carrie M. Nielson, Jon Fryzek, Hossam Saad, and Jeffrey Crawford. “Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 30:111–111, 2021.
Bylsma L, Nielson CM, Fryzek J, Saad H, Crawford J. Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 111–111.
Bylsma L, Nielson CM, Fryzek J, Saad H, Crawford J. Chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 111–111.

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

EISSN

1099-1557

ISSN

1053-8569

Publication Date

2021

Volume

30

Start / End Page

111 / 111

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences